KLEMP WALTER V (CEO and President) purchased 994.6% of their position (675.67K shares) of MOLECULIN BIOTECH, INC. on the open market
Open‑market purchase worth $250.0K — a major conviction buy. The strongest form of insider conviction signal.
Common Stock
Shares
+3.75K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−914.00
Price / share
$0.27
Trade value
$244.04
% of position
Common Stock
Shares
+8.99K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−2.19K
Price / share
$0.27
Trade value
$584.73
% of position
Common Stock
Shares
+675.67K
Price / share
$0.37
Trade value
$250K
% of position
Net shares
+685.31K
Net value
$249.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/20/2025 | M · Option Exercise | +3.75K | — | — | 6.4% | 58.30K | 62.05K |
| Common Stock Direct | 6/20/2025 | F · Tax Withholding | −914.00 | $0.27 | $244.04 | 1.5% | 62.05K | 61.13K |
| Common Stock Direct | 6/22/2025 | M · Option Exercise | +8.99K | — | — | 14.7% | 61.13K | 70.12K |
| Common Stock Direct | 6/22/2025 | F · Tax Withholding | −2.19K | $0.27 | $584.73 | 3.1% | 70.12K | 67.93K |
| Common Stock Direct | 6/23/2025 | P · Purchase | +675.67K | $0.37 | $250K | 994.6% | 67.93K | 743.61K |
| Total | +685.31K | $249.17K | ||||||
Restricted Stock Units
Common Stock
3.75K shares
Shares
−3.75K
Strike price
Held after
391.45K
Exercisable
—
Restricted Stock Units
Common Stock
8.99K shares
Shares
−8.99K
Strike price
Held after
382.46K
Exercisable
—
Series E Warrants
Common Stock
2.03M shares
Shares
−2.03M
Strike price
0.37
Held after
2.41M
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.75K shares | 6/20/2025 | M · Option Exercise | −3.75K | — | 391.45K | |
| Restricted Stock Units Direct | Common Stock8.99K shares | 6/22/2025 | M · Option Exercise | −8.99K | — | 382.46K | |
| Series E Warrants Direct | Common Stock2.03M shares | 6/23/2025 | P · Purchase | −2.03M | 0.37 | — | 2.41M |